Brian Stalter was Appointed as General Counsel at Cabaletta-Bio

Date of management change: September 05, 2019 

What Happened?

Philadelphia, -based Cabaletta-Bio Appointed Brian Stalter as General Counsel

 

About the Company

Cabaletta Bio is focused on the discovery and development of T cell therapies for B cell-mediated autoimmune diseases. Cabaletta`s therapeutic platform produces highly selective autologous Chimeric AutoAntibody Receptor (CAAR) T cells that are designed to precisely bind and destroy only specific autoantibody-producing B cells while sparing normal antibody-producing B cells, which are essential for human health. The platform is based on the revolutionary Chimeric Antigen Receptor (CAR) T cell technology developed at the University of Pennsylvania that resulted in one of the first commercially-available CAR T cell products for the treatment of B cell malignancies. Cabaletta has an exclusive global licensing agreement and multiple sponsored research agreements with the University of Pennsylvania to develop the CAAR T technology to treat B cell-mediated autoimmune diseases. The Company`s lead therapeutic program is a potential treatment for a prototypical B cell-mediated autoimmune disease, mucosal pemphigus vulgaris (mPV), which is a rare skin disorder that causes painful blisters and sores on mucous membranes leading to severe and sometimes debilitating and life-altering effects. An IND submission is planned for 2H19.

 

About the Person

Brian Stalter is General Counsel at Cabaletta Bio. Previously, Brian held various senior legal leadership roles in the industry.

 

Info Source

News

 
 

Other IT executives who recently changed jobs as well: Rutherford Randy, Raichilson Ryan, Crawford Addison, Dimitrief Alex, Nielson Guy, Gaines Heather, Dantes Sanchez Maria, Greenhut Steven, Marley Chilton Ann, Emmett Richard, Potter Whitney

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.